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COMMENTARY
Food as pharma: marketing nutraceuticals to India’s rural poor
Alice Street*
Social Anthropology, University of Edinburgh, Edinburgh, UK
(Received 4 April 2014; accepted 14 September 2014)
This commentary sketches out the politics of the expansion of affordable,
fast-moving nutraceutical products into rural India, with a focus on fortiﬁed
foods and beverages. It examines the relationships between industry, govern-
ment and humanitarian organisations that are being forged alongside the
development of markets for nutraceuticals; the production of evidence and the
harnessing of science to support nutraceutical companies’ claims; the ways in
which nutraceuticals are being marketed and distributed in rural areas; and the
concepts of health and well-being that are being promulgated through those
marketing campaigns. Lastly, it asks what kinds of impact fast-moving nutra-
ceuticals are likely to have on the lives of India’s rural poor. It concludes by
questioning how smooth a transition to nutraceutical consumption Big Food
marketing strategies can really facilitate and how readily low-income families
seeking to feed their families and safeguard health will actually adopt
concepts of wellness and internalise micro-nutrient associated risks.
Keywords: nutraceuticals; fortiﬁed food; India; bottom of the pyramid;
humanitarian technology
Introduction
In 2009, GlaxoSmithKline began test marketing an affordable brand of Horlicks™, its
ubiquitous malt-based drink, to be sold in 2.5 rupee sachets in villages across Andhra
Pradesh in South India. In marketing the product, which it called Asha™ (hope, in
Hindi), GlaxoSmithKline claimed it would provide poor rural consumers with an alter-
native to local cereal mixes of what they call ‘uncertain quality’, such as ﬁnger millet
malt. In 2011, PepsiCo India launched a new salty biscuit product called Lehar Iron
Chusti™, which it rolled out across Andhra Pradesh in 2 rupee packets, alongside a
major education campaign on iron deﬁciency for women and teenagers. At the same
time, in neighbouring Orissa, Coca-Cola was launching Vitingo™, a new sachet-based
orange-ﬂavoured drink fortiﬁed with 12 vitamins and minerals that it promoted as help-
ing to combat blindness, anemia and other common diseases, in collaboration with a
local NGO and self-help group.
These are all examples of what industry and marketing groups refer to as nutraceuti-
cals: nutritionally fortiﬁed or engineered foods, beverages or supplements that are mar-
keted for their health-giving properties. In recent years, Indian economists and market
research agencies have championed the Indian nutraceuticals market as a potential
engine of growth. With current growth rates exceeding 18% and market forecasts of a
ﬁvefold increase by 2020, nutraceuticals are celebrated as the most successful sector of
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the food and pharmaceuticals market (IKON Marketing Consultants, 2013; Indian
Business News Agency, 2012). In 2010, revenues from the Indian nutraceutical industry
were estimated at US $ 2 Billion (Frost & Sullivan, 2011, p. 5). By 2017, they are
expected to reach US $ 4.2 billion (Techsi Research, 2013). The potential for expansion
is deemed to be vast, with ‘an envisaged latent market of 148 million customers’ (Ernst
& Young, 2012, p. 25).
Until recently, the nutraceutical industry had concentrated on responding to the rise
in obesity and lifestyle diseases in India by marketing more expensive, higher margin
products to India’s aspirant middle class. Marketing consultants celebrate this popula-
tion as having a growing awareness of health and lifestyle diseases, rising disposable
incomes and, increasingly, a ‘self-care ethos’ that is associated with a demand for pre-
ventative healthcare products. To market analysts, food and beverage companies appear
to be dividing their urban portfolio into complementary segments of health and wellness
on the one hand and indulgence on the other (Gupta, 2009). Health and wellness prod-
ucts include sports beverages, diabetic foods and child health products. GlaxoSmithK-
line’s Horlicks™ is seen as the market leader in this area, with diversiﬁcation into
‘Standard’, ‘Women’s’ and ‘Children’s’ ranges, and securing 50% of the fortiﬁed bever-
age market in 2012. Horlicks™ is now the second-biggest selling beverage in India
after bottled water and has double the sales ﬁgures of Coca-Cola and Pepsi combined.
But with intense competition in the urban sector, the focus of both domestic and
multinational companies is now moving to the design of affordable nutraceutical goods
for consumers at the ‘bottom of the pyramid’; Indians who live on less than $2 a day
(Prahalad, 2009). This is a largely rural population whose anticipated purchasing power
is based on an economy of speed and scale rather than the size of individual incomes.
Where the penetration rate of nutraceuticals in urban areas is 22.51%, in rural areas it is
currently only 6.32%. For the growing nutraceutical industry and those seeking to make
new acquisitions in this area, this presents a huge ‘latent market’ that could ultimately
account for a third of the market scope (IKON Marketing Consultants, 2013).
The migration of the nutraceuticals industry into rural markets has seen the industry
shift away from the claim that their products can prevent non-communicable diseases
associated with urban working lifestyles, such as diabetes, cardiovascular disorders and
cancers, and towards the claim that products speciﬁcally designed for the rural poor can
tackle child malnutrition and save vulnerable lives. Such claims are couched in a lan-
guage of humanitarianism and focused on a target that the food industry increasingly
shares with the international development sector: micronutrient deﬁciency, its long-term
health implications and its national and global economic cost.
Today, India’s ‘double burden’ of obesity and malnutrition is a double opportunity.
With the rise of micronutrient deﬁciency as a development problem, an international
consensus has emerged around the corporate laboratory and marketing agency as the
solution (Kimura, 2013). Where government food programs in India have failed to
address rural malnutrition, it is anticipated that Big Food, with its scientiﬁc, marketing
and distribution capacities can succeed. Selling nutraceuticals to the rural poor, accord-
ing to governments; the food industry, a global community of market consultancy agen-
cies and accountancy ﬁrms; and the global development community, is a clear case of
‘doing well by doing good’.
This commentary sketches out the politics of the expansion of affordable, fast-moving1
nutraceutical products into rural India, with a focus on fortiﬁed foods and beverages.
It examines the relationships between industry, government and humanitarian organisa-
tions that are being forged alongside the development of markets for nutraceuticals; the
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production of evidence and the harnessing of science to support nutraceutical companies’
claims; the ways in which nutraceuticals are being marketed and distributed in rural areas;
and the concepts of health and wellbeing that are being promulgated through those
marketing campaigns. Lastly, it asks what kinds of impact fast-moving nutraceuticals are
likely to have on the lives of India’s rural poor. It concludes by questioning how smooth a
transition to nutraceutical consumption Big Food marketing strategies can really
achieve and how readily low-income families seeking to feed their families and safeguard
health will actually adopt concepts of wellness and internalise micro-nutrient associated
risks.
What are nutraceuticals?
The US physician, Dr Stephen De Felice, claims to have coined the term ‘nutraceuti-
cals’ in 1989 as follows: ‘A food or part of a food that provides medical or health ben-
eﬁts, including the prevention and/or treatment of a disease’. For De Felice, this
category includes any food that we already eat, but which molecular and clinical
research establishes as having a particular health beneﬁt. In other words, according to
this deﬁnition, a food can become a nutraceutical simply through the production of new
scientiﬁc knowledge. As food science has developed in relation to advances in molecu-
lar biology, the term has more commonly come to refer to foods that have been trans-
formed and enhanced through technological processes to have particular health-giving
properties. Such processes include the fortiﬁcation of foods with vitamins and minerals,
the biofortiﬁcation of food through plant breeding for nutrient-rich crops and the
manufacture of dietary supplements.
Despite the wide circulation of the term and its inclusion in the Oxford English
Dictionary, a review of the literature shows that nutraceuticals do not yet constitute a
legal entity or speciﬁc object of regulation in any country. Instead, the term has largely
been used and promoted by representatives from the global food industry, for whom the
nutraceutical’s association with scientiﬁc evidence and medicine generates additional
economic value. Indeed, nutraceuticals might be deﬁned as food products that have
been created solely for the capacity to make health claims about them (Katan & Roos,
2004; Schneider, n.d.).
How did the privately manufactured and marketed nutraceutical product also become
a cornerstone of the global development agenda? By the late 1990s, international develop-
ment organisations such as UNICEF or the World Bank, had shifted from talking about
hunger as a function of poverty and famine to talking about ‘hidden hunger’. The focus
was now on the quality as well as the quantity of food, and the qualities that foods have
were monitored at a molecular level. Hidden hunger was deﬁned as a lack of micronutri-
ents – vitamins and minerals such as iron, zinc, vitamin A and iodine. As the food sociolo-
gist Kimura notes, over the course of the 1990s, the hidden hunger concept slowly
accrued global authority through discussion at a series of international conferences on
nutrition, global food security and child health, including the 1990 World Summit for
Children, the 1991 Montreal meeting ‘ending hidden hunger’, the 1992 International
Conference on Nutrition and the 1996 World Food Summit (Kimura, 2008). The global
consensus that micronutrient deﬁciency is a high priority area is today indicated by its
incorporation into the programs of bi-lateral and multi-lateral development agencies such
as DFID and AUSAID and its inclusion in the ﬁrst Millennium Development Goal.2
The global distribution of micronutrient deﬁciency is now monitored, measured and
mapped by a growing number of international organisations and academics.3 By all
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these measures, India’s rates of hidden hunger are alarmingly high. India alone boasts
the world’s largest undernourished population – over 200 million. Fifty-six percent of
ever-married women and 70% of children under the age of ﬁve are anemic (Interna-
tional Institute for Population Science (IIPS) and Macro International, 2007) and at least
15% are at risk of iodine deﬁciency (Chakravarty & Sinha, 2002). In this context, the
affordable nutraceutical that is designed for the rural poor is celebrated as a humanitar-
ian technology, capable of relieving suffering and ameliorating the loss of life in
contexts of crisis (Cross, 2013; Redﬁeld, 2012).
The notion of hidden hunger has also been picked up by the international economic
community, who draw on medical research about the effects of micronutrient deﬁciency
on long-term health and mental development to make links between hidden hunger and
human capital. It is the shift from ‘general’ improvements in health to the speciﬁed
mental and physical beneﬁts of micronutrients that has been signiﬁcant for economists
at institutions like Asian Development Bank (ADB, 2004) and World Bank (2006):
well-nourished people, it is claimed, are able to ‘work harder and be potentially more
innovative …’ (Bekeﬁ, 2006, p. 8). The link between micronutrient deﬁciency and eco-
nomic development is rendered concrete and measured by disability-adjusted life years
(DALYs), with a recent study suggesting that India lost 1000 DALYs to micronutrient
deﬁciencies per 100,000 population (Muthayya et al., 2013, p. 8). Based partly on
DALY estimates, the Copenhagen Consensus of 2004 convened by a panel of distin-
guished economists determined that after the control of HIV/AIDS, providing micronu-
trients had the best economic beneﬁt-to-cost ratio of alleviating poverty in the
developing world (Copenhagen Consensus Center, 2004).
The notion of deﬁciency in vitamins or minerals is not new. Governments have
been providing vitamin and iron supplements, for example, to pregnant women since
the 1970s. However, the growing prominence of the concept of ‘micronutrients’ as a
scientiﬁc category and the concept of ‘hidden hunger’ as a major cause of ill-health and
poverty in the development industry has coincided with, on the one hand, developments
in food science that have enabled the isolation and transformation of individual bioac-
tive components in foods (Kim, 2012, p. 7) and on the other hand, the growing consen-
sus that food fortiﬁcation is the best solution to micronutrient deﬁciency.
Like its counterpart, obesity, micronutrient deﬁciency has been ‘artifactually con-
structed’ through epidemiological measures and economic algorithms in ways that shape
its problematisation and subsequent interventions (Guthman, 2013). Since the 1990s,
we have seen the demise of alternative solutions to micronutrient deﬁciency, such as
supplementation, kitchen gardens or dietary education, in favour of the notion that the
most effective and efﬁcient point of transformation for established diets is the corporate
laboratory (Morris, Cogill, & Uauy, 2008; Victora, 2009, p. 1124). As a World Bank
report describes food fortiﬁcation: ‘Probably no other technology available today offers
as large an opportunity to improve lives and accelerate development at such low cost
and in such a short time’ (The World Bank, 1994). Affordable fortiﬁed foods have
emerged as the site of opportunity in which market growth, healthy economies and
humanitarian ethics coincide.
Public-private partnership
With the shift from poverty and hunger to hidden hunger and micronutrient deﬁciency,
government responses to malnutrition have expanded from direct humanitarian action
through food aid to the creation of an ‘enabling environment’, in which affordable
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fortiﬁed food markets can ﬂourish. In India, the Integrated Child Development
Scheme began in 1975 as a subsidised food program that distributes basic foods such
as wheat and grain to poor families in anganwadi centres, village-level centres for
government-funded social welfare programmes. Yet, 30 years after the establishment of
the ICDS, the most recent National Family Health Survey reported that 48% of the
country’s children under 5 are stunted, 20% are wasted and 43% are underweight
(International Institute for Population Science (IIPS) and Macro International, 2007).
The state-sponsored food program has been widely criticised for its inefﬁciency and
corruption. More recently, the inﬂuential development economists Abhijit Banerjee and
Esther Duﬂo have argued that food subsidies, which are designed to ameliorate
poverty-related hunger, are an inadequate response to micronutrient deﬁciency because
they fail to address the fact that the poor can usually afford to buy enough food but
prioritise better-tasting food:
Developing ways to pack foods that people like to eat with additional nutrients, and com-
ing up with new strains of nutritious and tasty crops that can be grown in a wider range of
environments, need to become priorities for food technology, on an equal footing with rais-
ing productivity. (Banerjee & Duﬂo, 2011, 40)
Packing better-tasting food with micronutrients is where the private sector is seen to
have skills and resources that are not always available to governments. While the state
is still thought to have a role in regulation and facilitation, the private sector is increas-
ingly considered to have the intellectual property, manufacturing capacities and market-
ing skills needed to take food fortiﬁcation the last mile (Kimura, 2013). Public–private
partnership is now the favoured model for improving nutrition in developing countries
for the World Bank, the WHO and the Millennium Project taskforce on Hunger.
In 2002, the UN established the Global Alliance for Improved Nutrition (GAIN) as
a collaborative mechanism for business, civil society and governmental organisations to
address micronutrient challenges worldwide. GAIN received funding from the Bill and
Melinda Gates Foundation, the Canadian Development Agency, USAID and administra-
tive support from the UNDP. It provides funding for public–private national fortiﬁcation
programs, for research to remove technical challenges in food fortiﬁcation and to sup-
port market mechanisms for securing access to fortiﬁed foods. To obtain a GAIN grant,
the organisation requires that each country establish a National Fortiﬁcation Alliance,
made up of government and corporate membership, to ensure that the appropriate foods
are fortiﬁed and that they are made available through market mechanisms. GAIN aims
to provide corporations with technical assistance to scale up access to their products
through facilitating partnerships such as school feeding programs, joint awareness-
raising and educational activities with organisations such as UNICEF and the Flour
Fortiﬁcation Initiative, assistance in social marketing and helping to promote food forti-
ﬁcation through publications and reports. In 2008, GAIN opened an India ofﬁce to
assist NGOs and businesses to create and distribute ‘market viable’ fortiﬁed foods to
the rural population.
With funding from GAIN and the World Bank Institute, the Business Alliance for
Food Fortiﬁcation was launched in Beijing 2005 to promote relationships between the
food industry and the international development sector. The BAFF’s purpose, as stated
on their website, is to ‘identify new ﬁnancial mechanisms and new business models,
expand scientiﬁc knowledge and expertise in fortiﬁcation, and catalyse joint action
between companies, development partners, and government’. The private sector, it
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states, is crucial in providing the products, technology and marketing for the creation of
‘market-viable and sustainable food fortiﬁcation’. For multinational companies like
Coca-Cola or Unilever, who are co-chairs of the BAFF, or Danone, who joined the
GAIN board in 2006, these organisations create opportunities for collaboration and net-
working with representatives from government and development agencies, and access to
public and philanthropic funding and political support. All these companies are seeking
to expand their fortiﬁed foods portfolios in India.
Today, Coca-Cola, PepsiCo and GlaxoSmithKline each distribute and market their
bottom-of-the-pyramid nutraceutical products in partnership with local NGOs and mic-
roenterprise organisations. In many cases, these NGOs have received funding from glo-
bal organisations like UNICEF; in some cases, mediated by GAIN, to provide
educational programs on micronutrients in rural areas. Educational campaigns by NGOs
and development agencies that are run in concert with the rollout of new fortiﬁed food
products prime a market for corporate access. Such partnerships are indications of the
‘creeping privatisation of health education’ (Powell, 2014). For their Nutristar™ drink
fortiﬁed with patented triple-fortiﬁcation technology for iron, vitamin A and iodine, for
example, Proctor & Gamble partnered with UNICEF, who provided health education
about micronutrients, at the same time as Proctor & Gamble distributed the product.
These partnerships have also been crucial to ‘last-mile’ distribution strategies. In
Orissa, Coca-Cola partnered with the NGO BISWA to distribute Vitingo™ through self
help groups; in Andhra Pradesh, GlaxoSmithKline developed a partnership with SKS
Microﬁnance, a microcredit organisation, to distribute Asha™. The distribution of nutra-
ceutical products in rural areas is being tied into direct-selling employment opportuni-
ties, with rural distributors being both personal consumers of the product and social
conduits through whom companies can access wider social networks (Cross & Street,
2009). When GlaxosmithKline launched Asha™, it added 4000 sub-distributors to its
existing 500 distributors in small towns (Kashyap & Raut, 2008, p. 552).
To its champions, this partnership model for affordable nutraceuticals is celebrated
as a mechanism for enabling access to vital health products and an engine of entrepre-
neurship and rural employment (Dolan, Johnstone-Louis, & Scott, 2012). Yet, its critics
have highlighted the ways in which GAIN’s support for multinational companies crowd
out local businesses, leading to the loss of local industry and employment opportunities.
Meanwhile, nutritionists have raised questions about the nutritional quality of fortiﬁed
foods that are also laced with sugar and salt i.e. where ‘better tasting’ also corresponds
with being damaging to health (see Nestle, 2013) and social activists have queried the
potentially dangerous marketing activities of GAIN partners such as Nestle, in relation
to infant feeding and complementary foods for young children. In a decision that
appears to suggest such concerns are taken seriously, in January 2013, the WHO
decided to postpone formal relations with GAIN on the basis of its links to the food
industry and the need for further information on its partners’ compliance with WHO
nutritional policy (WHO, 2013).
Harnessing science
Key to the added value that fortiﬁcation lends food is its scientiﬁc evidence base. This
is also where multinational corporations have a distinct advantage over local competi-
tors. The acquisition of nutraceutical portfolios has become increasingly attractive to
corporations already invested in pharmaceuticals, such as GlaxoSmithKline. According
to market analysts, pharmaceuticals have increasingly narrow proﬁt margins, especially
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in developing world contexts where generics are providing greater competition (e.g.
Frost & Sullivan, 2011). Over the past three years, following consultant advice,
GlaxoSmithKline has begun to shed its pharmaceutical portfolio and expand its nutra-
ceutical portfolio in the BRIC economies. Nutraceuticals have lower proﬁt margins than
pharmaceuticals but require a fraction of the outlay on research and development
(IKON Marketing Consultants, 2013). At the same time, nutraceuticals are seen as an
opportunity for India’s food industry and fast-moving consumer goods industry to
increase revenues. Making claims about the health-giving qualities of particular prod-
ucts enables multi-nationals to sell more expensive products in a highly competitive,
often locally dominated, marketplace (Bourne Partners, 2013). In a widely circulated
newsletter, the accountancy ﬁrm Price Waterhouse Coopers (PWC) recently identiﬁed
increased collaboration between the fast-moving consumer goods(FMCG) sector and the
pharmaceutical industry as the primary opportunity for innovation in the nutraceuticals
sector (PWC, 2013).
A clear sign of the pharmaceuticalisation of food is the establishment of scientiﬁc
foundations and institutes by food and FMCG companies in India to generate the scien-
tiﬁc evidence needed to market their products as nutraceuticals. For example, Coca-Cola
established the Beverage Institute for Health & Wellness in 2004; Brittania established
the Brittania Nutritional Foundation in 2009; and GlaxoSmithKline launched the
Horlicks Nutrition Academy in 2011. These institutes conduct research to establish
micronutrient deﬁciency in target populations and on the products developed to meet
that deﬁciency. One effect of corporate-funded scientiﬁc research into micronutrient
deﬁciency is that homemade food and established diets are considered inadequate and
in need of fortiﬁcation with commercial foods that can be better quantiﬁed and moni-
tored in terms of their micronutrient content. As Kimura argues, ‘nutritionism’ – the
reduction of food to its nutritional qualities – has shifted authority over food production
and consumption from a domestic to scientiﬁc domain (Kimura, 2013). The Horlicks
Nutrition Academy website, for example, features photographs of scientists in white
coats and emphasises their expertise in nutritional science: ‘Our panel of scientists,
nutritionists and researchers are committed to provide you with the expertise and nutri-
tional solutions to help you lead a healthier life’.4 Indeed, Kimura argues that fortiﬁed
baby food is attractive to policy-makers precisely because of its ‘potential to bypass
mothers as the gatekeeper of babies’ health’ (Kimura, 2008, p. 234). Being a responsi-
ble mother in developing countries now entails ‘choosing’ food products that have
undergone corporate fortiﬁcation (ibid., p. 251).
GAIN actively encourages governments to endorse products that make scientiﬁcally
valid claims. And yet, as critics have pointed out, most of the scientiﬁc evidence for
the efﬁcacy of nutraceuticals is generated by the corporations themselves. Indeed, there
is almost no regulation of the effectiveness and quality of nutraceuticals in India, pre-
cisely because they do not occupy a distinct legal category from food and beverages. It
is therefore much easier to make health claims about fortiﬁed foods in India than drugs.
In making scientiﬁc claims, the nutraceutical industry has borrowed from the
pharmaceutical industry its dominant product testing mechanism: the randomised con-
trolled trial. The results of randomised controlled trials are converted into DALYs,
which enable corporations to scale up the ‘cost-effectiveness’ of nutraceutical products
to a national level. As critics have pointed out, however, randomised controlled trials
take place in highly controlled environments and tell us little about the impact of
nutraceuticals in places where compliance may not be high:
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The types of delivery systems used, country characteristics, year in which the study was
done, program characteristics, and costing methodologies contribute to the variability in
cost estimates found in the literature. It is not clear whether these cost estimates include
expenses necessary to attain such high compliance rates. (Berry, Mukherjee, & Shastry,
2012, p. 6)
What corporate-funded nutritional academies research and how, what is left out of those
studies (e.g. the effects of poor nutritional content, such as sugar and salt, or the local
availability of nutritional foods) and how evidence from those studies is subsequently
drawn on to market corporate products or garner political support demand enquiry
from social scientists equivalent to recent research on the politics of evidence in the
pharmaceutical industry (McGoey, 2012; Will & Moreira, 2010).
Selling wellness
How do you make a nutraceutical market for the rural poor? As the rising costs of
health care put it beyond reach of much of this population, investment analysts antici-
pate that they will become increasingly susceptible to notions of wellness and its associ-
ated products. And yet the cornerstone of ‘wellness’, the micronutrient, is not a familiar
concept for much of the Indian population: ‘The Indian consumer’s awareness about
conventional nutraceutical ingredients such as omega-3 fatty acids or lutein is severely
limited, and nutraceutical manufacturers need to take up the cause and spread awareness
about their products to the Indian masses’ (Frost & Sullivan, 2011, p. 5). The major
challenge in this area is considered to be that of translating the established acceptance
of alternative and herbal remedies and supplements in Indian ayurveda traditions into
concepts of ‘wellness’ and ‘micro-nutrient deﬁciency’. The problem is how to make
people think about their food and their bodies in terms of micronutrient content and the
long-term health risks associated with micronutrient deﬁciency.
One of the reasons why Horlicks, and the fortiﬁed beverage market in general, does
so well in India may be because the commodiﬁcation of ayurveda tonics is already well
established. Companies like Himalayan, for example, repackage ayurveda herbal prepa-
rations ‘in the symbolic forms of biomedical, “English”, medicine – brightly coloured
capsules, plastic bottles, English labels – and [distribute] it by prescription through bio-
medical physicians’ (Cohen, 2000, p. 133). Indeed, companies like Horlicks achieve
many of their sales through the prescription of their products by family physicians. As
one marketing analyst report put it: ‘The existence of alternative medicine in India, and
the Indian consumer’s belief in them, could provide a platform for the nutraceutical
industry to capitalize on’ (Frost & Sullivan, 2011, p. 5).
Recent research on nutraceuticals in medical anthropology and sociology has con-
centrated on the ways in which the transformation of food into a micronutrient health
product transforms people’s sense of self and their relationship to their body in ways
that afford new techniques of health governance (Herrick, 2011; Powell, 2014). It is
suggested that the introduction of nutraceuticals is associated with a growing concern
with the ‘risks’ of living (Kim, 2012) and the fostering of individual responsibility for
managing the risk of chronic disease. Food becomes another everyday space in which
we monitor our health status and ‘a molecular understanding of foods … expands into
the social realm’ (ibid., p. 12; Rose, 2007).
The majority of this research, however, has been carried out in urban, middle class
environments, often in middle- or high-income countries. As a consequence, there
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remains little understanding of the concepts of ‘wellness’ that may be emerging in the
context of nutraceutical products designed as humanitarian technologies for the rural
poor. In rural India, corporations recognise the need to market their affordable products
through associations with different aspirational teleologies from those they use to mar-
ket products to urban consumers. Where the standard Horlicks is marketed on the basis
of people’s aspirations for their children’s educational achievement and the prevention
of future ‘lifestyle’ diseases, for example, affordable Horlicks was rebranded as
‘Asha™’, meaning hope. This was partly to avoid contamination of the Horlicks brand
with ‘poor’ associations, but it also suggests that marketing agencies believe consump-
tion in rural families, where poor health and hunger may already be the norm, is not
oriented towards the prevention of ill-health, but rather a future where the health and
prospects of their children may improve. The product sells the possibility for survival
amidst the struggle to sustain life in the present.
Established supplementary food practices in rural India are seen by the nutraceutical
industry as an opportunity to sell fortiﬁed foods. But how easily can one set of foods
and practices be metaphorically extended to incorporate another? As education and mar-
keting campaigns are rolled out alongside nutraceutical products, will women in rural
Andhra Pradesh and Orissa internalise a notion of the molecular self? Will they see
commercially produced nutraceuticals as better, more scientiﬁcally valid versions of the
everyday foods that they give their children to promote vitality and growth? Or will nu-
traceuticals be received as overly expensive foods? The possibility that food marketing
experiments, such as those of micropackaging or direct selling, that are explicitly
designed to overcome obstacles associated with frontier markets in culturally unfamiliar
and logistically difﬁcult environments may be less successful than anticipated is sug-
gested by the disappearance of Asha™ from the GlaxoSmithKline website and the
absence of any publicly available information on the product since its test marketing
stage in 2010.
The hegemonic power exerted by multinational food companies through integrated
marketing techniques used to promote unhealthy foods is well documented (e.g.
Jackson, Harrison, Swinburn, & Lawrence, 2014). How successful rural marketing
techniques such as multilevel marketing are in promoting new concepts of health and
wellness is, by comparison, relatively underexplored. This is where future in-depth,
ethnographic research capable of detailing the rich worlds of food and health practices
into which multinational companies seek entry for their nutraceutical products will be
crucial.
Conclusion
On the one hand, new partnerships between international development organisations
and the food industry and new strategies for accessing nutraceutical markets at ‘the bot-
tom of the pyramid’ need to be approached critically. The increasingly dominant mes-
sage that commercially fortiﬁed foods are the solution to hidden hunger obviates the
importance of living conditions and structural impediments that may prevent families
from creating a balanced diet. Indeed, we should be asking why fortiﬁed foods have
replaced a balanced diet as the basis for nutritional health and what is at stake in such
transitions when they are made in the name of humanitarianism. As the nutritionist
Marion Nestle pointed out in 2002, ‘The complexity of food composition means that no
single nutrient is likely to work nearly so well as a diet rich in the fruits and vegetables
from which that nutrient was isolated’ (Nestle, 2013 [2002], Part Five).
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On the other hand, it is important to bear in mind the logistical, economic and cul-
tural limitations that multinational food companies face when they seek to make new
markets for nutraceutical products. It is tempting to emphasise the ‘smooth’ segue of
corporate capitalism into the world of humanitarian food (Errington, Fujikura, &
Gewertz, 2012). But the amalgamation of the values of proﬁt and humanitarianism in a
single nutraceutical product is an achievement that must be actively and repeatedly
brokered in the conference halls of the international development sector, the reports of
marketing consultants and analysts, the pot-holed roads of India’s rural districts and the
homes of rural distributors and Indian consumers. As research on analogous products,
such as the selling of soap (Cross & Street, 2009) or solar lanterns (Cross, 2013) as
public health goods has indicated, multinationals often encounter rougher social and
physical terrain in rural markets than they anticipate. Just how far the nutraceutical can
travel remains an important question for capitalists, development specialists, consumers
and social scientists alike.
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Notes
1. Fast-moving consumer goods refer to products sold quickly, at a low cost and often in a small
unit size.
2. Despite the apparent shift from quantity to quality, USAID’s food programs have recently been
attacked by Medecins Sans Frontieres on precisely the basis that the agricultural surplus they
are ofﬂoading onto poor countries through their food aid program fails to meet the United
States’ own nutritional standards. See http://www.msf.org/article/open-letter-us-government-
about-quality-food-aid.
3. See, for example, the World Health Organisation (WHO) database on anaemia http://www.who.
int/vmnis/database/anaemia/en/; the wiki map of iron deﬁciency adjusted DALY’s using data
from WHO, http://commons.wikimedia.org/wiki/File:Iron-deﬁciency_anaemia_world_map_-
_DALY_-_WHO2002.svg; The World Bank’s regional table of DALYs lost by attributing to
nutritional deﬁciencies (Caulﬁeld, Richard, Rivera, Musgrove, & Black, 2006) and the micronu-
trient initiative’s overview of data limitations http://www.micronutrient.org/resources/publica
tions/mn_report.pdf; and most recently, the creation of a hidden hunger index and its mapping
in relation to DALY’s (Muthayya et al., 2013).
4. http://www.horlicksnutritionacademy.com/AboutHNA.aspx.
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